Related Experiment Video
Updated: Nov 24, 2025
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Nanoparticles for Stem Cell Therapy Bioengineering in Glioma
Henry Ruiz-Garcia1,2, Keila Alvarado-Estrada2, Sunil Krishnan1
1Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, United States.
Abstract:
Gliomas are a dismal disease associated with poor survival and high morbidity. Current standard treatments have reached a therapeutic plateau even after combining maximal safe resection, radiation, and chemotherapy. In this setting, stem cells (SCs) have risen as a promising therapeutic armamentarium, given their intrinsic tumor homing as well as their natural or bioengineered antitumor properties. The interplay between stem cells and other therapeutic approaches such as nanoparticles holds the potential to synergize the advantages from the combined therapeutic strategies. Nanoparticles represent a broad spectrum of synthetic and natural biomaterials that have been proven effective in expanding diagnostic and therapeutic efforts, either used alone or in combination with immune, genetic, or cellular therapies. Stem cells have been bioengineered using these biomaterials to enhance their natural properties as well as to act as their vehicle when anticancer nanoparticles need to be delivered into the tumor microenvironment in a very precise manner. Here, we describe the recent developments of this new paradigm in the treatment of malignant gliomas.
Insights
Stem cells and nanoparticles offer a novel approach to treating malignant gliomas, overcoming current treatment limitations. This combination enhances targeted delivery and antitumor properties for improved glioma therapy.
Area of Science:
- Oncology
- Biomedical Engineering
- Nanotechnology
Background:
- Malignant gliomas present significant therapeutic challenges with limited survival rates.
- Current treatments like surgery, radiation, and chemotherapy have plateaued in efficacy.
- Stem cells (SCs) show promise due to tumor-homing and antitumor capabilities.
Purpose of the Study:
- To explore the synergistic potential of combining stem cells and nanoparticles for glioma treatment.
- To review recent advancements in using bioengineered stem cells with nanoparticles for glioma therapy.
Main Methods:
- Review of current literature on stem cell and nanoparticle applications in glioma research.
- Discussion of bioengineering strategies for enhancing stem cell therapeutic properties.
- Analysis of nanoparticle-mediated drug delivery systems utilizing stem cells.
Main Results:
- Stem cells can be bioengineered with nanoparticles to improve their antitumor functions.
- Nanoparticles enhance the precise delivery of therapeutic agents to the tumor microenvironment.
- Combined strategies show potential for synergistic therapeutic effects in preclinical models.
Conclusions:
- The combination of stem cells and nanoparticles represents a promising new paradigm for malignant glioma treatment.
- This approach leverages the strengths of both stem cells and nanotechnology for enhanced efficacy.
- Further research is warranted to translate these findings into clinical applications for glioma patients.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
09:18Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018